MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Detection of novel acoustic biomarkers among Parkinson’s disease patients via an explainable machine learning model

    K. Tsutsumi, P. Chang, S. Isfahani (San Diego, USA)

    Objective: Our aim was to develop and compare machine learning (ML) algorithms for identification of Parkinson’s disease (PD) patients via acoustic analysis of vowel articulation…
  • 2025 International Congress

    Advancing Hypomimia Assessment in Parkinson’s Disease by Integrating a Continuous Monitoring Device into Clinical Practice

    A. Wiederhold, C. Gundler (Hamburg, Germany)

    Objective: We aim to establish a robust, continuous method for monitoring hypomimia in Parkinson’s disease (PD), bridging the gap between sporadic clinical evaluations and real-life…
  • 2025 International Congress

    Feature Extraction and Classification Using Smartphone-Based Alternating Tapping Tasks for Distinguishing Parkinson’s Disease from Healthy Individuals

    V. Ratanasirisawad, P. Panyakaew, O. Phokaewvarangkul, J. Sringean, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To determine whether a smartphone-based alternating tapping task can reliably differentiate Parkinson’s disease (PD) from healthy controls and to identify the tapping metrics that…
  • 2025 International Congress

    Neurogenic bladder and affective disorders in parkinsonism

    E. Korshunova, M. Khommyatov, M. Samushiya, N. Suponeva (Moscow, Russian Federation)

    Objective: To determine the relationship between psychoemotional and dysuria dysfunctions in patients with PD and MSA. Background: In the group of patients with extrapyramidal pathology…
  • 2025 International Congress

    Specialized palliative care for advanced Parkinsonian syndromes: bridging the gap

    K. Cantu Flores, E. Mcrae, K. Waldmann, R. Kline, V. Bruno (Calgary, Canada)

    Objective: The Advanced Care Team for Parkinson’s (ACT-PD) pilot program at the Calgary Movement Disorders Clinic aimed to bridge gaps in specialized palliative care for…
  • 2025 International Congress

    Gut Dysbiosis Alters Host Metabolism but Does Not Independently Induce Parkinson’s Disease Pathology

    HY. Huang, TH. Yeh, SP. Tsao (Taipei, Taiwan)

    Objective: To determine whether gut dysbiosis alone is sufficient to induce Parkinson’s disease (PD) pathology and to investigate its impact on host metabolism. Background: Gut…
  • 2025 International Congress

    Transformation of Parkinson’s care through Self-Management, Remote monitoring and Timely review (SMaRT-PD): Care Pathway Mapping with Clinical Experts

    N. Howe, P. Walker, C. Mutepfa, S. Pretorius, A. Ponzo, C. Carroll, J. Suklan (Plymouth, United Kingdom)

    Objective: To elicit healthcare professionals’ perspectives on the introduction of a clinical decision support system (CDSS) to facilitate Parkinson’s disease care provision: impact on current…
  • 2025 International Congress

    Utility of Digital Olfactory Assessment (Sensify) in Parkinson’s Disease: Preliminary Findings from the IPDGC Africa in Egypt

    N. Shebl, S. Mondal, F. Waheed, A. Farag, N. Abonar, M. Abdelhady, S. Asran, M. Salama, M. Rizig (Cairo, Egypt)

    Objective: Validate a digital olfactory assessment for Parkinson’s disease (PD) in Egyptian participants by comparing olfactory performance in PD patients, healthy controls, and those with…
  • 2025 International Congress

    Artificial Intelligence for Understanding Parkinson Disease State and Patient Stratification Using CSF Proteomics

    L. Abu Zohair, H. Zantout, M. Vallejo, M. Uddin (Edinburgh, United Kingdom)

    Objective: The objective of this research is to employ an Artificial Intelligence (AI) approaches to identify patient status and disease states in neurodegenerative diseases (NDDs),…
  • 2025 International Congress

    Diagnostic Work Up when Suspecting Early Onset Parkinson Disease (EOPD) Recommendations from the MDS EOPD Study Group

    R. Mehanna, C. Marras, J. Fleisher, B. Post, K. Kumar, A. Noyce, R. Alcalay, H. Morris, T. Hatano, M. Salari, K. Smilowska, Y. Wu, B. Zhang, E. Tan, R. Savica (Houston, USA)

    Objective: Objective: To establish recommendations regarding which investigations are needed for the diagnosis of Early onset Parkinson’s disease (EOPD) Background: Background: EOPD has been defined…
  • « Previous Page
  • 1
  • …
  • 87
  • 88
  • 89
  • 90
  • 91
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley